https://www.selleckchem.com/pr....oducts/gsk2334470.ht
The primary outcome is total blood loss. The secondary outcomes are blood transfusion rate, drainage volume, plasma D-dimer, PAI-1, TAT and F1+2 levels, maximum haemoglobin drop, wound complications, VTE and length of hospital stay. This study's protocol is in accordance with the declaration of Helsinki. The ethics committee of the General Hospital of Ningxia Medical University approved this study (approval ID 2020-505). The results of this study will be disseminated in international peer reviewed journals. ChiCTR2000030624. ChiCTR20
Like
Comment
Share
